High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinomaJAE YONG CHO; HYUN CHEOL CHUNG; SUNG HOON NOH et al.Cancer. 1997, Vol 79, Num 5, pp 878-883, issn 0008-543XConference Paper

Comparison of Two Inflammation-Based Prognostic Scores in Patients with Unresectable Advanced Gastric CancerJEONG, Jae-Heon; SUN MIN LIM; JI YOUNG YUN et al.Oncology. 2012, Vol 83, Num 5, pp 292-299, issn 0030-2414, 8 p.Article

Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/ metastatic biliary tract carcinomaJAE YONG CHO; YONG HAN PAIK; YOON SOO CHANG et al.Cancer. 2005, Vol 104, Num 12, pp 2753-2758, issn 0008-543X, 6 p.Article

Salvage Chemotherapy with Docetaxel and Epirubicin for Advanced/Metastatic Gastric CancerJAE YUN LIM; JAE YONG CHO; YONG HAN PAIK et al.Oncology. 2007, Vol 73, Num 1-2, pp 2-8, issn 0030-2414, 7 p.Article

Outcome of Adjuvant Therapy for Gallbladder CancerHYUNG SOON PARK; JAE YUN LIM; DONG SUP YOON et al.Oncology. 2010, Vol 79, Num 3-4, pp 168-173, issn 0030-2414, 6 p.Article

Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancerCHANG HOON HAN; JAE YONG CHO; JONG TAE MOON et al.Oncology reports. 2006, Vol 16, Num 6, pp 1205-1210, issn 1021-335X, 6 p.Article

Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinomaJAE YONG CHO; JOO HANG KIM; YI HYEONG LEE et al.Cancer. 1997, Vol 79, Num 3, pp 462-467, issn 0008-543XArticle

A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancerHONG SUK SONG; YOUNG ROK DO; HEUNG MOON CHANG et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 5, pp 763-768, issn 0344-5704, 6 p.Article

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trialBANG, Yung-Jue; KIM, Young-Woo; YOUNG JAE MOK et al.Lancet (British edition). 2012, Vol 379, Num 9813, pp 315-321, issn 0140-6736, 7 p.Article

Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II studyKYUNG HEE LEE; MIN KYOUNG KIM; JAE YONG CHO et al.Cancer chemotherapy and pharmacology. 2009, Vol 64, Num 2, pp 317-325, issn 0344-5704, 9 p.Article

Retrospective comparison of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (modified FAM) combination chemotherapy versus palliative therapy in treatment of advanced gastric cancerJOON OH PARK; HYUN CHEOL CHUNG; JAE KYUNG ROH et al.American journal of clinical oncology. 1997, Vol 20, Num 5, pp 484-489, issn 0277-3732Article

Gene Expression Signature-Based Prognostic Risk Score in Gastric CancerJAE YONG CHO; JAE YUN LIM; SUNG HOON NOH et al.Clinical cancer research (Print). 2011, Vol 17, Num 7, pp 1850-1857, issn 1078-0432, 8 p.Article

Effects of interleukin-2 transduction on the human hepatoma cell lines using retroviral vectorJOO HANG KIM; SOO JUNG GONG; HYUN CHEOL CHUNG et al.Oncology reports. 1998, Vol 6, Num 1, pp 49-54, issn 1021-335XArticle

AMPKα Modulation in Cancer Progression: Multilayer Integrative Analysis of the Whole Transcriptome in Asian Gastric CancerYON HUI KIM; HAN LIANG; YONGMING SUN et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 10, pp 2512-2521, issn 0008-5472, 10 p.Article

Are There Any Ethnic Differences in Molecular Predictors of Erlotinib Efficacy in Advanced Non-Small Cell Lung Cancer?AHN, Myung-Ju; PARK, Byeong-Bae; CHANG HAK SOHN et al.Clinical cancer research. 2008, Vol 14, Num 12, pp 3860-3866, issn 1078-0432, 7 p.Article

Relationship between p53 overexpression and gastric cancer progressionKIM, J.-H; HYO DONG UHM; NAE CHOON YOO et al.Oncology. 1997, Vol 54, Num 2, pp 166-170, issn 0030-2414Article